Mangalam Drugs & Organics Ltd. Financial Overview
Mangalam Drugs & Organics Ltd.'s market cap is currently ₹519.48M. The company's EPS TTM is ₹-4.641; its P/E ratio is ―; Mangalam Drugs & Organics Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.